Hidekata Yasuoka Selected Research

Hidekata Yasuoka Research Topics

Disease

11	Immunoglobulin G4-Related Disease 01/2021 - 05/2014
11	Fibrosis (Cirrhosis) 01/2020 - 12/2005
10	Systemic Scleroderma (Systemic Sclerosis) 01/2020 - 12/2003
8	Rheumatoid Arthritis 01/2021 - 09/2014
5	Connective Tissue Diseases (Connective Tissue Disease) 11/2020 - 12/2003
3	Interstitial Lung Diseases (Interstitial Lung Disease) 02/2022 - 01/2020
3	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2018
3	Idiopathic Pulmonary Fibrosis 01/2019 - 11/2006
3	Mixed Connective Tissue Disease (MCTD) 01/2018 - 10/2004
3	Pulmonary Arterial Hypertension 02/2015 - 11/2013
2	Fever (Fevers) 02/2022 - 01/2018
2	Dermatomyositis (Dermatopolymyositis) 02/2022 - 10/2020
2	Lymphadenopathy 01/2021 - 01/2016
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 11/2006
2	Necrosis 01/2020 - 03/2004
2	Multi-centric Castleman's Disease 12/2017 - 01/2017
2	Inflammation (Inflammations) 11/2016 - 10/2009
2	Myasthenia Gravis 12/2005 - 04/2003
1	Myositis (Idiopathic Inflammatory Myopathies) 02/2022
1	Muscular Diseases (Myopathy) 02/2022
1	Polymyositis 02/2022
1	Eosinophilia 01/2021
1	Virus Diseases (Viral Diseases) 11/2020
1	Acro-Osteolysis (Acroosteolysis) 01/2020
1	Calcinosis 01/2020
1	Osteoarthritis 01/2020
1	Synovitis 10/2019
1	Lung Diseases (Lung Disease) 01/2019
1	Disease Progression 01/2018
1	Amyloidosis 01/2018
1	Arthritis (Polyarthritis) 01/2018
1	Cranial Nerve Diseases (Cranial Nerve Disorders) 01/2018
1	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 01/2018
1	Keratitis 02/2016
1	Takayasu Arteritis (Arteritis, Takayasu's) 02/2016
1	Rheumatic Diseases (Rheumatism) 01/2016
1	digital ulcers 02/2015

Drug/Important Bio-Agent (IBA)

9	Immunoglobulin G (IgG)IBA 01/2021 - 09/2015
7	AutoantibodiesIBA 02/2022 - 12/2003
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2003
6	CollagenIBA 01/2020 - 11/2006
6	Insulin-Like Growth Factor Binding Protein 5IBA 01/2019 - 09/2006
5	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2016
4	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 01/2015
4	GlucocorticoidsIBA 01/2021 - 09/2015
4	tocilizumab (atlizumab)FDA Link 05/2020 - 01/2015
4	CytokinesIBA 10/2019 - 03/2004
4	Insulin-Like PeptidesIBA 01/2019 - 11/2006
4	Fibronectins (Fibronectin)IBA 01/2019 - 11/2006
3	AntibodiesIBA 02/2022 - 10/2004
3	InterleukinsIBA 01/2021 - 03/2004
3	beta-cyclodextrin tetradecasulfate (CTDS)IBA 11/2020 - 10/2012
3	Insulin-Like Growth Factor Binding ProteinsIBA 01/2014 - 11/2006
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2018
2	interleukin-21 (interleukin 21)IBA 01/2021 - 10/2018
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 01/2019
2	Abatacept (Orencia)FDA Link 11/2020 - 09/2014
2	Interleukin-6 (Interleukin 6)IBA 10/2019 - 12/2017
2	Interleukin-4 (Interleukin 4)IBA 10/2018 - 09/2015
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 10/2004
2	Epoprostenol (Prostacyclin)FDA LinkGeneric 05/2014 - 11/2013
2	Insulin-Like Growth Factor Binding Protein 3IBA 10/2009 - 01/2008
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 10/2009 - 08/2009
2	AntigensIBA 12/2005 - 11/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2004 - 12/2003
1	Ligases (Synthetase)IBA 02/2022
1	Epidermal Growth Factor (EGF)IBA 01/2021
1	iguratimodIBA 01/2021
1	milk fat globuleIBA 01/2021
1	Chemokine CCL26IBA 01/2021
1	glucose utilization inhibitor (IGU)IBA 01/2021
1	cyclic citrullinated peptideIBA 11/2020
1	DNA (Deoxyribonucleic Acid)IBA 11/2020
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 01/2020
1	anti-scl-70 autoantibodiesIBA 01/2020
1	Infliximab (Remicade)FDA Link 01/2020
1	anticentromere antibodyIBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2019
1	Interleukin-10 (Interleukin 10)IBA 10/2019
1	Interleukin-8 (Interleukin 8)IBA 10/2019
1	Interleukin-2 Receptors (IL 2 Receptor)IBA 05/2018
1	Immunoglobulin E (IgE)IBA 05/2018
1	Immunoglobulin M (IgM)IBA 05/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	C-Reactive ProteinIBA 01/2018
1	LigandsIBA 01/2018
1	Vasodilator Agents (Vasodilators)IBA 01/2018
1	CC ChemokinesIBA 01/2018
1	Immunoglobulin A (IgA)IBA 01/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 02/2015
1	erucylphosphocholineIBA 02/2015
1	PTX3 proteinIBA 02/2015
1	Tumor Necrosis Factor InhibitorsIBA 01/2015
1	Biological ProductsIBA 09/2014

Therapy/Procedure

5	Therapeutics 01/2018 - 12/2003
1	Aftercare (After-Treatment) 05/2018
1	Renal Dialysis (Hemodialysis) 01/2018
1	Lasers (Laser) 02/2016
1	Slit Lamp 02/2016